Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles. [electronic resource]
Producer: 20181231Description: 6855-6870 p. digitalISSN:- 1178-2013
- Acridines -- administration & dosage
- Animals
- Carcinoma, Hepatocellular -- drug therapy
- Cell Death -- drug effects
- Doxorubicin -- administration & dosage
- Drug Delivery Systems
- Drug Synergism
- Endocytosis -- drug effects
- Hep G2 Cells
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Mice, Nude
- Nanoparticles -- administration & dosage
- Neoplastic Stem Cells -- drug effects
- Polyesters -- chemistry
- Polyethylene Glycols -- chemistry
- Rats, Sprague-Dawley
- Stem Cell Transplantation
- Stem Cells -- cytology
- Subcutaneous Tissue -- drug effects
- Tetrahydroisoquinolines -- administration & dosage
- Tissue Distribution
- Tumor Stem Cell Assay
- Vitamin E -- chemistry
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.